Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Thursday, February 6, 2025, at 9:00 a ...

Compared to its American brethren, Altria Group, which had an 8.6% cigarette volume decline last quarter, Philip Morris ...

Morgan Stanley lowered the firm’s price target on Altria Group (MO) to $53 from $54 and keeps an Equal Weight rating on the ...

Philip Morris (PM) has received a new Buy rating, initiated by Morgan Stanley analyst, Eric Serotta.Invest with Confidence: Follow TipRanks' ...

When paired with dividend reinvestment, high-yield dividend stocks have demonstrated remarkable outperformance compared to ...

With Q4 earnings season kicking off, let us take a closer look at the consumer staples sector performance and its constituent ...

Philip Morris International (NYSE:PM – Get Free Report) is projected to release its earnings data before the market opens on Thursday, February 6th. Analysts expect Philip Morris International to post ...

IQOS's success in Egypt signals a promising opportunity for the introduction of additional smoke-free products to the market, ...

Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10. Eric Serotta has given his Buy rating due to a combination of factors that ...

In this article, we are going to take a look at where Philip Morris International Inc. (NYSE ... research factoring in ...

The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical ...

The growth of Philip Morris's smoke-free portfolio is anticipated to be driven by the international momentum of its IQOS brand, the robust growth of Zyn, and the upcoming U.S. launch of IQOS.